CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
14897-39-3 | 利福霉素钠; (12Z,14E,24E)-(2S,16S,17S,18R,19R,20R,21S,22R,23S)-21-乙酰氧基-1,2-二氢-6,9,17,19-四羟基- | Rifamycin sodium salt; 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione,5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-,21-acetate, sodium salt (8CI); Rifamycin, monosodium salt (9CI); 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan, rifamycin deriv.; CB 01-11; Monosodium rifamycin SV; NSC 146718; Rifamycin SV sodium; RifamycinSV sodium salt; Rifamycin sodium; Rifamycin sodium salt; Tuborin | C37H46NNaO12 | 详情 | 供应商 | |
142959-76-0 | Cyclo(L-a-aspartyl-L-glutaminyl-L-tryptophyl-L-phenylalanylglycyl-L-leucyl)(9CI); 1,4,7,10,13,16-Hexaazacyclooctadecane,cyclic peptide deriv.; MEN 10354 | C37H46N8O9 | 详情 | 供应商 | ||
155521-01-0 | D-Phenylalanine,N6-[N-(2,3-dihydroxybenzoyl)glycyl]-L-lysyl-N6-(2,3-dihydroxybenzoyl)-L-lysyl-(9CI); D-Phenylalanine,N-[N6-(2,3-dihydroxybenzoyl)-N2-[N6-[N-(2,3-dihydroxybenzoyl)glycyl]-L-lysyl]-L-lysyl]-; Amonabactin P 750 | C37H46N6O11 | 详情 | 供应商 | ||
220185-38-6 | Phosphine,1,5-pentanediylbis[bis(3,5-dimethylphenyl)- (9CI); 1,5-BIS[BIS(3,5-DIMETHYLPHENYL)PHOSPHINO]PENTANE | C37H46P2 | 详情 | 供应商 | ||
299975-19-2 | Phosphonium,[10-(2,5-dihydroxy-3,4-dimethoxy-6-methylphenyl)decyl]triphenyl-, bromide (1:1); Phosphonium,[10-(3,6-dihydroxy-4,5-dimethoxy-2-methylphenyl)decyl]triphenyl-, bromide (9CI) | C37H46BrO4P | 详情 | 供应商 | ||
55576-66-4 | C37H46O12 | 详情 | 供应商 | |||
880262-14-6 | ((4R,5R)-(+)-O-[1-Benzyl-1-(5-methyl-2-phenyl-4,5-dihydrooxazol-4-yl)-2-phenylethyl](dicyclohexylpho; ((4R,5R)-(+)-O-[1-Benzyl-1-(5-methyl-2-phenyl-4,5-dihydrooxazol-4-yl)-2-phenylethyl](dicyclohexylphosphinite)(1,5-COD)iridium(I)tetrakis(3,5-bis(trifluoromethyl)phenylborate,min.97%; ((4R,5R)-(+)-O-[1-Benzyl-1-(5-methyl-2-phenyl-4,5-dihydrooxazol-4-yl)-2-phenylethyl] (dicyclohexylphosphinite)(1,5-COD)iridium(I) tetrakis(3,5-bis(trifluoromethyl)phenylborate, min. 97% | C37H46NO3P.C32H12BF24.C8H12.Ir | 详情 | 供应商 | ||
192725-39-6 | Lopinavir Metabolite M-1; (aS)-N-[(1S,3S,4S)-4-[[(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-a-(1-methylethyl)-2,4-dioxo-1(2H)-Pyrimidineacetami-d; Lopinavir Metabolite M-1; (aS)-N-[(1S,3S,4S)-4-[[(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-α-(1-methylethyl)-2,4-dioxo-1(2H)-Pyrimidineacetami- de; (aS)-N-[(1S,3S,4S)-4-[[(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-a-(1-methylethyl)-2,4-dioxo-1(2H)-Pyrimidineacetami-de | C37H46N4O6 | 详情 | 供应商 | ||
356060-82-7 | Methyl-6-O-(triisopropylsilyl)-2,3,4-tri-O-benzoyl-α-D-galactopyranoside | C37H46O9Si | 详情 | 供应商 | ||
55697-65-9 | 1-[4-氯-3-[[4,5-二氯-5-氧代-1-(2,4,6-三氯苯基)-1H-吡唑-3-基]-氨基]苯基]-3-(1-十八烯基)-2,5-吡咯烷二? | N-[4-CHLORO-3-[4,5-DIHYDRO-5-OXO-1-(2,4,6-TRICHLOROPHENYL)-1 H-PYRAZOL-3-YLAMINO]PHENYL]-2-(1-OCTADE; 1-[4-Chloro-3-[[4,5-dihydro-5-oxo-1-(2,4,6-trichlorophenyl)-1H-pyrazol-3-yl]amino]phenyl]-3-(1-octadecenyl)-2,5-pyrrolidinedione; 2,5-pyrrolidinedione,1-[4-chloro-3-[[4,5-dihydro-5-oxo-1-(2,4,6-trichloropheny; 5-Pyrrolidinedione,1-[4-chloro-3-[[4,5-dihydro-5-oxo-1-(2,4,6-trichlorophenyl)-1H-pyrazol-3-yl]amin2; chloro-dihydrooxotrichlorophenylpyrazolyl-aminoph; l)-1h-pyrazol-3-yl]amino]phenyl]-3-(1-octadecenyl)-; N-[4-CHLORO-3-[4,5-DIHYDRO-5-OXO-1-(2,4,6-TRICHLOROPHENYL)-1 H-PYRAZOL-3-YLAMINO]PHENYL]-2-(1-OCTADECENYL)SUCCINIMIDE; 1-(2,4,6-TRICHLOROPHENYL)-3-[2-CHLORO-5-(1-OCTADECENYL-1-SUCCINIMIDO)ANILINO]-2-PYRAZOLIN-5-ONE; LABOTEST-BB LT00453358 | C37H46Cl4N4O3 | 详情 | 供应商 |